Gliclazide

Gliclazide

Cat. No.: DIA-0230825

Size: 50 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 21187-98-4
Formula C15H21N3O3S
Molecular Weight 323.41
SMILES CC1=CC=C(C=C1)[S](=O)(=O)NC(=O)NN2CC3CCCC3C2
Product Description Gliclazide is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM.
Format & Storage
Purity > 98%
Shipping Shipped on dry ice.
Storage Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top